Literature DB >> 21428970

Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo.

R Kumar1, D Parsad, A J Kanwar, D Kaul.   

Abstract

BACKGROUND: Vitiligo is characterized by the loss of functional melanocytes from the epidermis. Repigmentation in vitiligo is initiated by activation, proliferation and migration of melanoblasts from the outer root sheath of hair follicles, or melanocytes from the border area of vitiligo lesions, into the depigmented epidermis. Cell migration plays a crucial role during repigmentation in vitiligo.
OBJECTIVES: To investigate the role of matrix metalloproteinases (MMPs) and their transcription factor Ets-1 in vitiligo.
METHODS: Skin biopsies were taken from 15 patients with vitiligo and six controls to culture melanocytes from clinically active perilesional and normal skin. Expression of MMP-1, MMP-2, MMP-9 and Ets-1 was examined by reverse transcriptase-polymerase chain reaction analysis. Expression of Ets-1 was also confirmed with Western blot analysis. Activity of MMP-2 and MMP-9 was assessed using gelatin zymography.
RESULTS: The activity of MMP-2 and MMP-9 was significantly lower in patients with vitiligo compared with the controls. The expression of MMP-2 and MMP-9 was also significantly lower in patients with vitiligo. There was no expression of Ets-1 transcription factor at either the transcriptional or translational level in melanocytes cultured from patients with vitiligo.
CONCLUSION: The absence of a basal level of expression of Ets-1 significantly decreases the expression and activity of MMP-2 and MMP-9. Significant decreases in MMP-2 and MMP-9 activity could possibly reduce the migration of melanocyte precursors (melanoblasts) from the outer root sheath of hair follicles or migration of melanocytes from the border of vitiligo lesions into clinically depigmented epidermis which is crucial to the repigmentation of vitiliginous skin.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21428970     DOI: 10.1111/j.1365-2133.2011.10324.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

1.  Fractional Er:YAG laser assisting topical betamethasone solution in combination with NB-UVB for resistant non-segmental vitiligo.

Authors:  Ru Yan; Jinping Yuan; Hongqiang Chen; Yuan-Hong Li; Yan Wu; Xing-Hua Gao; Hong-Duo Chen
Journal:  Lasers Med Sci       Date:  2017-07-14       Impact factor: 3.161

2.  Effect of combination of fractional CO2 laser and narrow-band ultraviolet B versus narrow-band ultraviolet B in the treatment of non-segmental vitiligo.

Authors:  Mohamed Bakr El-Zawahry; Naglaa Sameh Zaki; Marian Youssry Wissa; Marwah Adly Saleh
Journal:  Lasers Med Sci       Date:  2017-07-26       Impact factor: 3.161

3.  Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.

Authors:  Nesrine Boukhedouni; Christina Martins; Anne-Sophie Darrigade; Claire Drullion; Jérôme Rambert; Christine Barrault; Julien Garnier; Clément Jacquemin; Denis Thiolat; Fabienne Lucchese; Franck Morel; Khaled Ezzedine; Alain Taieb; François-Xavier Bernard; Julien Seneschal; Katia Boniface
Journal:  JCI Insight       Date:  2020-06-04

4.  The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis.

Authors:  Woo Il Kim; Sooyoung Kim; Sang Hoon Lee; Moon Kyun Cho
Journal:  Lasers Med Sci       Date:  2020-06-23       Impact factor: 3.161

Review 5.  Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.

Authors:  Stanca A Birlea; Gertrude-E Costin; Dennis R Roop; David A Norris
Journal:  Med Res Rev       Date:  2016-12-28       Impact factor: 12.944

Review 6.  Fractional CO2 laser contributes to the treatment of non-segmental vitiligo as an adjunct therapy: a systemic review and meta-analysis.

Authors:  Yu-Jen Chiu; Cherng-Kang Perng; Hsu Ma
Journal:  Lasers Med Sci       Date:  2018-04-26       Impact factor: 3.161

7.  Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells.

Authors:  Tünde Szatmári; Filip Mundt; Ghazal Heidari-Hamedani; Fang Zong; Elena Ferolla; Andrey Alexeyenko; Anders Hjerpe; Katalin Dobra
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

8.  Liver X Receptor-α polymorphisms (rs11039155 and rs2279238) are associated with susceptibility to vitiligo.

Authors:  Silky Agarwal; Gurjinder Kaur; Rohit Randhawa; Vikram Mahajan; Rohit Bansal; Harish Changotra
Journal:  Meta Gene       Date:  2016-02-10

Review 9.  Clinical and Molecular Aspects of Vitiligo Treatments.

Authors:  Anuradha Bishnoi; Davinder Parsad
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

10.  Human pigmentation: A side effect adapted from a primitive organism's survival. Part 2: The melanocyte as mentor of the keratinocye.

Authors:  Sanju Arianayagam; Terence J Ryan
Journal:  Indian Dermatol Online J       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.